Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Deglutition Disorders × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 204 Breast Neoplasms 112 Neoplasms 89 Prostatic Neoplasms 32 Fatigue 27 Obesity 22 Colorectal Neoplasms 20 Lung Neoplasms 15 Colonic Neoplasms 15 Polycystic Ovary Syndrome 13 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Lymphoma 9 Lymphedema 9 Hematologic Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Brain Neoplasms 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Cardiotoxicity 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Overweight 5 Lymphoma, Follicular 5

Interventions

Radiotherapy 3 Cisplatin 3 Cryotherapy 2 Carboplatin 2 Acupuncture Therapy 2 tislelizumab 1 pembrolizumab 1 epigallocatechin gallate 1 durvalumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Tablets 1 Standard of Care 1 Resistance Training 1 Range of Motion, Articular 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Pravastatin 1 Parenteral Nutrition 1 Paclitaxel 1 Nivolumab 1 Niacinamide 1 Musculoskeletal Manipulations 1 Lead 1 Immunotherapy 1 Hyaluronic Acid 1 Gastropexy 1 Fundoplication 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03455608 2024-12-10

PRO-ACTIVE

University Health Network, Toronto

Phase NA Completed

Deglutition Disorders, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡